CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
100% watermelon juice +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03626168
NCT03626168N/ACompleted

Bioactive Compounds in Watermelon Modulating Oxidative Stress and Inflammation in Elders: The MOXIE Study

University of Alabama, Tuscaloosa·interventional·Posted Aug 10, 2018·Updated May 17, 2022

In Brief

A clinical study evaluating 100% watermelon juice and Placebo beverage for Arterial Stiffness and Inflammation. Completed, enrolled 21 participants.

Detailed Summary

Watermelon is the only food with a unique combination of amino acids and antioxidants that may reduce artery stiffness. However, only 27% of older adults meet the daily recommendation for fruit intake. Because it tastes good and is convenient and easy to consume, watermelon juice is an innovative and impactful intervention to help elders easily meet recommendations for fruit servings. If effective, this intervention would be a simple, inexpensive way to combat cardiovascular diseases (CVD). Results will advance science by providing a better understanding whether four-week consumption of 100% watermelon juice may impact measures of vascular health and inflammation in postmenopausal women.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 10, 2018
Enrollment StartFeb 16, 2016
Primary CompletionMay 12, 2018
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 7.9 years ago

Interventions

100% watermelon juicedietary

Participants drank two 12-ounce servings of 100% watermelon juice per day for a four-week period.

Placebo beverageother

Participants drank two 12-ounce servings of a placebo beverage per day for a four-week period.